A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Alex Parks

Contributor News

Biopharma news Women in tech

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

Olaris CEO Elected to Personalized Medicine Coalition Board of Directors

   275
Olaris CEO Elected to Personalized Medicine Coalition Board of Directors

Dr. Elizabeth O’Day will lead personalized medicine investment and adoption efforts globally during three-year term  

WALTHAM, Mass., June 9, 2020 — Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced that The Personalized Medicine Coalition (PMC) has elected Olaris CEO and Founder Dr. Elizabeth O’Day to serve a three-year term on the PMC Board of Directors.